Nabi have signed two international distribution agreements for Nabi-HB [Hepatitis B Immune Globulin (Human)] with Biotech Medical Corporation of Malaysia and Innovative Biotech PTE LTD, a corporation of the Republic of Singapore. Global expansion of Nabi-HB continues to be a key objective for Nabi Biopharmaceuticals, according to David Gury, chairman, president and CEO. “Our agreements Read more about Nabi Expands Global Presence[…]